| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $222.7M | +34.0% |
| Gross Profit | $180.0M | +43.5% |
| R&D Expense | $34.9M | +87.9% |
| SG&A Expense | $51.6M | +68.9% |
| Operating Income | -$44.0M | -76.3% |
| Interest Expense | $8.4M | -67.5% |
| Pre-tax Income | -$41.9M | +30.9% |
| Income Tax | -$17.7M | -2721.9% |
| Net Income | -$7.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.9M | -62.1% |
| Short-term Investments | $184.9M | — |
| Accounts Receivable | $58.8M | +35.7% |
| Current Assets | $413.7M | -6.9% |
| Total Assets | $2.12B | +0.3% |
| Current Liabilities | $140.6M | +19.4% |
| Long-term Debt | $266.4M | -2.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.6M | +41.1% |
| Capital Expenditures | $8.3M | +23.7% |
| Investing Cash Flow | -$248.9M | -432.6% |
| Financing Cash Flow | -$26.7M | -106.9% |
| Free Cash Flow | $27.3M | +47.5% |
| +59.1% |
| EPS (Basic) | -$0.07 | +63.2% |
| EPS (Diluted) | -$0.07 | +63.2% |
| Total Liabilities |
| $640.7M |
| +4.6% |
| Stockholders' Equity | $1.48B | -1.4% |